Ellipse Technologies, Inc. Completes Enrollment for the Initial Clinical Trial of the MAGEC Remote Control, Non-Invasive System for the Treatment of Scoliosis

IRVINE, Calif.--(BUSINESS WIRE)--Ellipse Technologies, Inc. (“Ellipse”) announced it had completed the initial clinical study enrollment for its MAGECTM (MAGnetic Expansion Control) Technology in “At Risk Early Onset Scoliosis Patients.”